DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN EPILEPSY

被引：124
|
作者：
OVERWEG, J
BINNIE, CD
MEIJER, JWA
MEINARDI, H
NUIJTEN, STM
SCHMALTZ, S
WAUQUIER, A
机构：
[1] JANSSEN PHARMACEUT,B-2340 BEERSE,BELGIUM
[2] EPILEPSY CTR,DETROIT,MI
来源：
EPILEPSIA | 1984年 / 25卷 / 02期
关键词：
D O I：
10.1111/j.1528-1157.1984.tb04178.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：217 / 222
页数：6
相关论文
共 50 条
  • [31] Efficacy of ozone therapy as an add-on treatment in fibromyalgia: A randomized double-blind placebo-controlled study
    Sucuoglu, Hamza
    Soydas, Nalan
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2023, 36 (02) : 357 - 366
  • [32] Dapagliflozin as Add-On Therapy to Sitagliptin With or Without Metformin: A Randomized, Double-Blind, Placebo-Controlled Study
    Jabbour, Serge
    Hardy, Elise
    Sugg, Jennifer
    Parikh, Shamik
    DIABETES, 2012, 61 : A275 - A276
  • [33] COGNITIVE AND ELECTROPHYSIOLOGICAL EFFECTS OF TIAGABINE ADD-ON THERAPY - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    RIEKKINEN, PJ
    KALVIAINEN, R
    AIKIA, M
    MERVAALA, E
    SAUKKONEN, AM
    PITKANEN, A
    NEUROLOGY, 1994, 44 (04) : A321 - A321
  • [34] GABAPENTIN (NEURONTIN) AS ADD-ON THERAPY IN PATIENTS WITH PARTIAL SEIZURES - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    ANHUT, H
    ASHMAN, P
    FEUERSTEIN, TJ
    SAUERMANN, W
    SAUNDERS, M
    SCHMIDT, B
    BAUER, G
    DEISENHAMMER, E
    KLINGLER, D
    MAMOLI, B
    GRAF, M
    DANTA, G
    BERKOVIC, S
    VAJDA, F
    BUCHANAN, N
    SCHAPEL, G
    BLACK, A
    BAJADA, S
    DEBARSY, T
    LATERRE, C
    VANZANDIJCKE, M
    MCLACHLAN, RS
    PURVES, SJ
    LEE, MA
    BRUNI, J
    GAWEL, M
    HOLTLARSEN, B
    WERDELIN, L
    DALBY, MA
    IIVANAINEN, MV
    GIROUD, M
    LECLERCQ, E
    REMY, C
    SALLOU, C
    RICHENS, A
    BILL, PLA
    EPILEPSIA, 1994, 35 (04) : 795 - 801
  • [35] Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
    Mohammad, Talar A. Merza
    Mohammad, Tavgah A. Merza
    Salman, Dyar M.
    Jaafar, Halmat M.
    PHARMACOPSYCHIATRY, 2024, 57 (04) : 205 - 214
  • [36] A randomised, double-blind, placebo-controlled, 39 week trial of ITCA 650 as add-on therapy in type 2 diabetes
    Baron, M. A.
    Buse, J.
    Azeem, R.
    Kjems, L.
    Rosenstock, J.
    DIABETOLOGIA, 2015, 58 : S55 - S55
  • [37] Improvement of Schizophrenia Negative and Positive Symptoms With Memantine as Add-On Therapy to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial
    de Lucena, David
    Fernandes, Brisa
    Berk, Michael
    Dood, Seetal
    Medeiros, Dalton W.
    Pedrini, Mariana
    Kunz, Mauricio
    Gomes, Fabiano
    Giglio, Larriany
    Lobato, Maria Ines
    Belmonte-de-Abreu, Paulo
    Gama, Clarissa S.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 211S - 211S
  • [38] Sulthiame in the primary therapy of West syndrome: A randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication
    Debus, OM
    Kurlemann, G
    EPILEPSIA, 2004, 45 (02) : 103 - 108
  • [39] Improvement of schizophrenia negative and positive symptoms with memantine as add-on therapy to clozapine: a double-blind, randomized, placebo-controlled trial
    Lucena, D.
    Fernandes, B.
    Berk, M.
    Dodd, S.
    Medeiros, D. W.
    Pedrini, M.
    Kunz, M.
    Gomes, F.
    Giglio, L.
    Lobato, M. I.
    Belmonte-de-Abreu, P.
    Gama, C. S.
    BIPOLAR DISORDERS, 2009, 11 : 57 - 57
  • [40] Levetiracetam (Keppra®) as add-on therapy for idiopathic generalised epilepsy syndromes:: Analysis of two randomised, double-blind, placebo-controlled studies
    Hiersemenzel, R.
    Rosenfeld, W.
    Edrich, P.
    Tonner, F.
    EPILEPSIA, 2007, 48 : 371 - 371
12345